Delivery Order SPE2DB24D2003-SPE2DB25FXKU2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,607.06 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on July 18, 2025, with completion scheduled for July 21, 2025. This firm fixed price delivery order represents a non-competitive award and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control and weight management within military and federal...
- The Defense Logistics Agency awarded a $10,019.57 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens (0.5 ml units). This competitively awarded, firm fixed-price contract will be completed by July 21, 2025, with performance taking place at the vendor's Corporate Office in Conshohocken, Pennsylvania. The award represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $25,619.20 by the Defense Logistics Agency on July 18, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors. This firm fixed-price delivery order, which carries an ultimate completion date of July 21, 2025, represents a non-competitive set-aside transaction and will be performed at the company's Corporate Office location in Conshohocken, PA....
- The Defense Logistics Agency awarded a $3,633.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on July 18, 2025, with completion scheduled for July 21, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. The product will be delivered to AmerisourceBergen's...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mounjaro 15 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a ceiling value of $1,632.54 and is a firm fixed price, non-set-aside delivery order with a performance period ending on May 8, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a...
- This is a $41,134.84 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the drug Mounjaro 15 mg/0.5 ml pen, a medication used to treat diabetes. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- The Defense Logistics Agency awarded a $23,763.47 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens under a firm fixed price contract. This delivery order, which is neither set-aside nor restricted, is scheduled for completion by July 21, 2025, with fulfillment occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for blood sugar management, reflecting the company's role as a...
- The Defense Logistics Agency awarded a $2,192.46 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical product 4561708819, described as Mounjaro 2.5 MG/0.5 ML pen injectors. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between August 4-7, 2023. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, this order for diabetic treatment aids is consistent with DLA's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Mounjaro 12.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $4,165.98 and a period of performance through May 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency Troop Support Medical awarded a $2,104 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the provision of 4561353533, which is the National Drug Code for Mounjaro 5 mg/0.5 ml pen injectors. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from June 27, 2023 through June 28, 2023 and utilizes a firm fixed price contract type. As a major provider...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXKU2Delivery Order
The Defense Logistics Agency awarded a $6,530.16 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injectors, with completion targeted for July 21, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA. The product will be performed and delivered from the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that enables comprehensive global pharmaceutical support across the military healthcare system. The IDC vehicle provides the company authority to supply a broad range of medications, vaccines, and medical supplies to support Defense Health Agency operations and other federal healthcare customers. AmerisourceBergen's role as a major pharmaceutical distributor and a DLA prime vendor demonstrates its established capability to meet federal medical procurement requirements at scale, with this specific delivery order fulfilling acute demand for diabetes management medication within the defense supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 7/18/25 |